Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Intraductal, Noninfiltrating × FAPI-46 × 1 year × Clear all

Sponsor

Conditions

Stomach Neoplasms 3 Pancreatic Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Testicular Neoplasms 2 Sarcoma 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Brain Neoplasms 2 Adrenal Gland Neoplasms 2 Vaginal Neoplasms 1 Uterine Neoplasms 1 Thymus Neoplasms 1 Solitary Fibrous Tumors 1 Skin Neoplasms 1 Salivary Gland Neoplasms 1 Penile Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Neoplasms, Unknown Primary 1 Hematologic Neoplasms 1 Colorectal Neoplasms 1

Interventions

Specimen Handling 8 Tamoxifen 7 Radiotherapy 5 exemestane 3 Radiation 3 Letrozole 3 Anastrozole 3 Surveys and Questionnaires 2 Sentinel Lymph Node Biopsy 2 Radiation Dose Hypofractionation 2 Patient Navigation 2 Observation 2 Metformin 2 Mastectomy 2 Magnetic Resonance Spectroscopy 2 Biopsy 2 trastuzumab biosimilar HLX02 1 poly ICLC 1 palbociclib 1 fezolinetant 1 elacestrant 1 afimoxifene 1 abemaciclib 1 Trastuzumab 1 Testosterone 1 Tablets 1 Surgical Procedures, Operative 1 Steroids 1 Standard of Care 1 Selective Estrogen Receptor Modulators 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡